Stevens-Johnson syndrome natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
SJS proper (with less than 10% of body surface area involved) has the [[mortality rate]] of around 5%. The risk for death can be estimated using the '''SCORTEN scale''', which takes a number of prognostic indicators into account.Other outcomes include organ damage and blindness. | SJS proper (with less than 10% of body surface area involved) has the [[mortality rate]] of around 5%. The risk for death can be estimated using the '''SCORTEN scale''', which takes a number of prognostic indicators into account. Other outcomes include organ damage and blindness. | ||
==References== | ==References== |
Revision as of 14:47, 26 March 2013
Stevens-Johnson syndrome Microchapters |
Differentiating Stevens-Johnson Syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Stevens-Johnson syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Stevens-Johnson syndrome natural history, complications and prognosis |
FDA on Stevens-Johnson syndrome natural history, complications and prognosis |
CDC on Stevens-Johnson syndrome natural history, complications and prognosis |
Stevens-Johnson syndrome natural history, complications and prognosis in the news |
Blogs on Stevens-Johnson syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
SJS proper (with less than 10% of body surface area involved) has the mortality rate of around 5%. The risk for death can be estimated using the SCORTEN scale, which takes a number of prognostic indicators into account. Other outcomes include organ damage and blindness.